BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 19010256)

  • 1. Introduction to "A road map for intravenous iron and anemia management: preparing for the future".
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S1-4. PubMed ID: 19010256
    [No Abstract]   [Full Text] [Related]  

  • 2. A comprehensive vision for intravenous iron therapy.
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic considerations in a changing anemia environment.
    Pizzi LT
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S29-33. PubMed ID: 19010259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin variability in dialysis patients.
    Brimble KS; Clase CM
    J Am Soc Nephrol; 2007 Aug; 18(8):2218-20. PubMed ID: 17627931
    [No Abstract]   [Full Text] [Related]  

  • 5. Finding a rational approach to ESA therapy--for payers and patients.
    Messana A
    Nephrol News Issues; 2007 Sep; 21(10):54, 56. PubMed ID: 17918481
    [No Abstract]   [Full Text] [Related]  

  • 6. Anemia management protocols: providing consistent hemoglobin outcomes.
    Michael M
    Nephrol Nurs J; 2005; 32(4):423-6. PubMed ID: 16180783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenge of effectively using erythropoiesis-stimulating agents and intravenous iron.
    Kapoian T
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S21-8. PubMed ID: 19010258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triumph and tragedy: anemia management in chronic kidney disease.
    Novak JE; Szczech LA
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):580-8. PubMed ID: 18941350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?
    Swinkels DW; Wetzels JF
    Nephrol Dial Transplant; 2008 Aug; 23(8):2450-3. PubMed ID: 18495744
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation.
    Vaziri ND
    Am J Med; 2012 Oct; 125(10):951-2. PubMed ID: 22795817
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical practice guidelines for evidence-based use of erythropoietic-stimulating agents.
    Moist LM; Foley RN; Barrett BJ; Madore F; White CT; Klarenbach SW; Culleton BF; Tonelli M; Manns BJ;
    Kidney Int Suppl; 2008 Aug; (110):S12-8. PubMed ID: 18668116
    [No Abstract]   [Full Text] [Related]  

  • 12. Treating anemia with erythropoiesis-stimulating agents: effects on quality of life.
    Moossavi S; Freedman BI
    Arch Intern Med; 2009 Jun; 169(12):1100-1. PubMed ID: 19546408
    [No Abstract]   [Full Text] [Related]  

  • 13. Correcting iron-restricted erythropoiesis and improving anemia in patients on hemodialysis: practical tips that can make a difference.
    Easom A
    Nephrol Nurs J; 2009; 36(5):529-37, 553. PubMed ID: 19856814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoglobin control, ESA resistance, and regular low-dose IV iron therapy: a review of the evidence.
    Singh A
    Semin Dial; 2009; 22(1):64-9. PubMed ID: 19175537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral or parenteral iron therapy in haemodialysis patients?
    Winney RJ; Swainson CP; Parker AC; Bone JM; Robson JS
    Proc Eur Dial Transplant Assoc; 1977; 14():184-91. PubMed ID: 600955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment experience with anemia in chronic kidney failure patients].
    Shostka GD
    Klin Med (Mosk); 1984 Jun; 62(6):60-6. PubMed ID: 6471800
    [No Abstract]   [Full Text] [Related]  

  • 17. Iron supplementation in renal anemia.
    Fishbane S
    Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To treat or not to treat renal anemia of chronic kidney disease patients?
    Tsubakihara Y
    Ther Apher Dial; 2010 Jun; 14(3):235-9. PubMed ID: 20609177
    [No Abstract]   [Full Text] [Related]  

  • 19. New developments in anemia management in chronic kidney disease.
    Amerling R; Besarab A; Roy C
    Nephrol News Issues; 2008 Mar; 22(3):suppl 1-8. PubMed ID: 18372676
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous iron therapy in peritoneal dialysis patients: short-term efficacy and long-term issues.
    Zager RA
    Clin J Am Soc Nephrol; 2006 May; 1(3):353-5. PubMed ID: 17699230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.